wegovy glp-1 pharmaceutical company overview Agonists Weight Loss Drugs Market Report, 2025-2030 GLP-1 Drugs For Weight Loss

Les groupes risque comprennent galement les femmes enceintes, les personnes ges, les personnes atteintes de pancratite et de diabte sucr de type 2

[PubMed: 17909402] 170

Reported side effects are typically mild: Morning grogginess: Uncommon, usually associated with initial dosing or timing adjustments Vivid dreams: Some patients report more vivid dreams, which may reflect enhanced REM sleep Headache: Occasionally reported, usually mild and transient Injection site reactions: Minor redness or discomfort at the injection site DSIP has not demonstrated significant interactions with common medications in published studies

Boden G, Sargrad K, Homko C, Mozzoli M, Stein TP, et al

A., Qian, X., Reigle, L., Woods, A., Wu, J